- Home
- SKM vs LEGN Comparison
SKM vs LEGN Comparison
Compare SKM & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKM
- LEGN
- Stock Information
- Founded
- SKM 1984
- LEGN 2014
- Country
- SKM South Korea
- LEGN United States
- Employees
- SKM N/A
- LEGN N/A
- Industry
- SKM Telecommunications Equipment
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- SKM Telecommunications
- LEGN Health Care
- Exchange
- SKM Nasdaq
- LEGN Nasdaq
- Market Cap
- SKM 8.2B
- LEGN 7.0B
- IPO Year
- SKM 1996
- LEGN 2020
- Fundamental
- Price
- SKM $21.15
- LEGN $35.06
- Analyst Decision
- SKM
- LEGN Strong Buy
- Analyst Count
- SKM 0
- LEGN 13
- Target Price
- SKM N/A
- LEGN $79.17
- AVG Volume (30 Days)
- SKM 341.1K
- LEGN 1.1M
- Earning Date
- SKM 05-07-2025
- LEGN 03-11-2025
- Dividend Yield
- SKM 3.15%
- LEGN N/A
- EPS Growth
- SKM 16.46
- LEGN N/A
- EPS
- SKM 3.90
- LEGN N/A
- Revenue
- SKM $12,144,590,272.00
- LEGN $627,241,000.00
- Revenue This Year
- SKM $2.21
- LEGN $66.60
- Revenue Next Year
- SKM $1.83
- LEGN $49.28
- P/E Ratio
- SKM $9.69
- LEGN N/A
- Revenue Growth
- SKM 1.89
- LEGN 119.97
- 52 Week Low
- SKM $19.88
- LEGN $30.17
- 52 Week High
- SKM $24.58
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- SKM 42.36
- LEGN 44.07
- Support Level
- SKM $21.21
- LEGN $34.00
- Resistance Level
- SKM $21.47
- LEGN $36.20
- Average True Range (ATR)
- SKM 0.23
- LEGN 1.52
- MACD
- SKM -0.02
- LEGN -0.25
- Stochastic Oscillator
- SKM 8.33
- LEGN 25.18
About SKM SK Telecom Co. Ltd.
SK Telecom is South Korea's largest wireless telecom operator, with 32 million mobile customers. The firm also owns SK Broadband (formerly Hanaro Telecom), which has 7.2 million broadband customers and 9.6 million pay TV customers (6.8 million IPTV and 2.8 million Cable TV). While the firm also purchased stakes in businesses in security and semiconductor memory production as well as developing e-commerce and internet platform businesses, these were all spun off into the separate, SK Square business in November 2021. The company was formed after SK Group purchased KT's mobile business in 1994.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.